多参数超声识别高危NASH:推导与验证研究
本研究为横断面二次分析,基于日本NAFLD队列(111例)推导联合肝硬度、衰减系数和色散斜率的LAD NASH评分,用于识别高危NASH(NAS≥4且纤维化≥F2),并在韩国NAFLD队列(102例)验证,推导集AUC 0.86、验证集AUC 0.88,推导集阳性预测值86.5%、阴性预测值87.5%。
要点
- LAD NASH评分联合肝硬度、衰减系数和色散斜率三个超声指标。
- 推导集AUC 0.86,验证集AUC 0.88,诊断性能满意。
- 推导集阳性预测值86.5%,阴性预测值87.5%。
核心结论
- 联合三个超声标记的LAD NASH评分可能有助于无创识别高危NASH患者,以供临床试验和药物治疗筛选。
研究设计与样本
- 横断面二次分析,数据为2017年4月至2019年3月前瞻性收集的日本NAFLD患者(推导集,111例,年龄20-89岁,57例男性,84例(76%)NASH)。
- 验证集为独立的韩国NAFLD数据集(102例,年龄20-78岁,43例男性,55例(36%)NASH)。
- 采用二维剪切波弹性成像测量肝硬度(LS,单位kPa)、衰减系数(AC,单位dB/cm/MHz)和色散斜率(DS,单位m/s/kHz),并结合AST、ALT及AST/ALT比值。
- 以多元逻辑回归确定最佳模型,以受试者工作特征曲线下面积(AUC)评估诊断性能。
诊断标准与关键数值
- 高危NASH定义为NAS≥4且临床显著纤维化(F2或更高)。
- LAD NASH评分推导集AUC 0.86(95%CI:0.79,0.93),验证集AUC 0.88(95%CI:0.80,0.95)。
- 推导集高危NASH阳性预测值86.5%,阴性预测值87.5%。
临床应用与阅片要点
- 在NAFLD患者超声评估中,可联合测量LS、AC和DS计算LAD NASH评分,辅助筛选高危NASH。
- 评分高者提示需进一步评估或纳入临床试验/药物治疗,评分低者高危NASH可能性较低。
局限性
- 本研究为横断面二次分析,非前瞻性验证。
- 推导集和验证集分别来自日本和韩国,样本量有限,外推至其他人群需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Nonalcoholic fatty liver disease (NAFLD) is common in the general population but identifying patients with high-risk nonalcoholic steatohepatitis (NASH) who are candidates for pharmacologic therapy remains a challenge. Purpose To develop a score to identify patients with high-risk NASH, defined as NASH with an NAFLD activity score (NAS) of 4 or greater and clinically significant fibrosis (stage 2 [F2] or higher). Materials and Methods This was a cross-sectional secondary analysis of data prospectively collected between April 2017 and March 2019 for a group of patients with NAFLD in Japan (Japan NAFLD, the derivation data set) with contemporaneous two-dimensional shear-wave elastography and biopsy-proven NAFLD (age range, 20-89 years). Three US markers (liver stiffness [LS, measured in kilopascals], attenuation coefficient [AC, measured in decibels per centimeter per megahertz], and dispersion slope [DS, measured in meters per second per kilohertz]) were determined, together with aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels and the AST-to-ALT ratio. The best-fit multivariate logistic regression model for identifying patients with high-risk NASH was determined. Diagnostic performance was assessed by using the area under the receiver operating characteristic curve (AUC). The findings were validated in an independent data set (Korea NAFLD; age range, 20-78 years). Results The Japan NAFLD data set included 111 patients (mean age, 53 years ± 18 [standard deviation]; 57 men), 84 (76%) with NASH. The Korea NAFLD data set included 102 patients (mean age, 48 years ± 18; 43 men), 55 (36%) with NASH. The most predictive model (LAD NASH score) combined LS, AC, and DS. Performance was satisfactory in both the derivation sample (AUC, 0.86; 95% CI: 0.79, 0.93) and the validation sample (AUC, 0.88; 95% CI: 0.80, 0.95). The LAD NASH score showed a positive predictive value of 86.5% and a negative predictive value of 87.5% for high-risk NASH in the derivation sample. Conclusion A score combining three US markers may be useful for noninvasive identification of patients with high-risk nonalcoholic steatohepatitis for inclusion in clinical trials and pharmacologic therapy. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Lockhart in this issue.
引用
- Sugimoto K, Lee DH, Lee JY, et al. Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study. Radiology. 2021. PMID: 34519576. doi:10.1148/radiol.2021210046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。